Abstract
Cardiovascular disease (CVD) is a major complication and cause of mortality in Takayasu arteritis (TA). The frequency of cardiovascular, cerebrovascular and renal morbidity or risk of death in TA is unknown in the UK. Population-based controlled studies are lacking in this area.
Original language | English |
---|---|
Journal | Arthritis and Rheumatology |
Publication status | Accepted/In press - 28 Aug 2020 |